Index
Checking point of information
at the time of initial public offering.
AI Analysis
■AI Analysis
AI statistically analyzes IPO information to identify trends.
The closer the number is to 5, the higher the rate of increase in the initial price relative to the offering price.
| popularity | scale-criteria | offering-criteria | exchange-criteria | market-condition | Business-criteria |
| 5 | 1 | 5 | 5 | 2 | 1 |
*This is an analysis of trends and does not guarantee any results.
This is not a solicitation to buy or sell stocks, nor is it investment advice.
*Please check the disclaimer for details.
■AI Analysis Chart
A group of stocks listed in the past
with similar IPO condition trends
| Name | Rate of change
(Inicial Price) |
|
| +27.8% |
|
| +21.6% |
|
| +57.9% |
|
| +25.8% |
|
| +300.0% |
|
| +26.5% |
CompanyOverview
- Company Name：Modalis Therapeutics Corporation
- Business：コアとなるプラットフォーム技術である『切らないCRISPR技術（CRISPR-GNDM技術）』を用いた遺伝子治療薬の研究開発.
- The industry sector is Pharmaceutical.
- Scheduled to be listed on MOTHERS.
- The company size is that assumed market capitalization is
approx. 301 Million JPY (excluded public offering), approx. 326 Million JPY (included public offering).
- The lead manager is みずほ.
https://www.modalistx.com/jp/
Initial Public Offering Memo
■ Market Cap | Offering rate | Dilution rate | lock-up information
- The company size is assumed market capitalization is
approx. 301 Million JPY (excluded new issues), approx. 326 Million JPY (included new issues).
- The total amount of new issues is 25.2 Million JPY.
- The total amount of public offering is 12.1 Million JPY.
- The dilution ratio from the new issues is 8%.
- Rate of offering is aprrox. 4%.
- The number of outstanding shares is 25,100,000 shares (excluded new issues),
27,200,000 shares (included new issues).
- The number of diluted shares for stock acquisition rights is 2,903,200 shares.
- Date of 90-day lockup release (initially scheduled) is October 31, 2020.
- Date of 180-day lockup release (initially scheduled) is January 29, 2021.
■ Book building schedule | Payment schedule
- Book building Period *1：July 14, 2020(Tue.) - July 20, 2020(Mon.)
- Priced date *2 ：July 21, 2020(Tue.)
- Payment Period *3 ：July 22, 2020(wed.) - July 29, 2020(wed.)
- Listing Date ：August 3, 2020(Mon.)
*1:(Period for applying lottery to obtain the right to purchase)
*2:(The date when the purchase price is determined)
*3:(Period for expressing your intent to purchase and payment,if you are selected in the lottery)
■ Detail of new issue or public offering
- Unit of application：100 shares (Minimum deposit amount is 120,000 JPY.)
- Assumed issue price：820 JPY
- Tentatively price range：1000 JPY - 1200 JPY
- Public offering price：1200 JPY
- The initial price on listed：2520 JPY(＋110.0％)
- Newly Issued Shares：2,100,000 shares (Domestic：1,404,000 shares ＋ Overseas：696,000 shares)
- Public offering shares：1,005,000 shares (Domestic：1,005,000 shares ＋ Overseas：0 shares)
- Number of domestic unit：24,090 Unit
- The lead manager is みずほ証券.
- The another securities companies are ＳＢＩ証券/ＳＭＢＣ日興証券/いちよし証券/エース証券.
| みずほ |
ＳＢＩ |
ＳＭＢＣ日興 |
いちよし |
エース |
| Lead |
Sub |
Sub |
Sub |
Sub |
■ New issue or public offering - condition history
|
Update
date |
Assumed issue
price
(JPY) |
Tentatively
price range
(JPY) |
Public offering
price
(JPY) |
| Initial | 2020-06-26 | 820 JPY | | |
| Application period | 2020-07-13 | | 1000 - 1200 JPY | |
| Priced | 2020-07-21 | | | 1200 JPY |
|
Update
date |
New issues
total shares |
New issues
(Overseas) |
PO&OA
total shares |
PO
(Domestic) |
PO
(Overseas) |
OA
(Domestic) |
OA
(Overseas) |
| Initial | 2020-06-26 | 2,100,000 | 0 | 1,005,000 | 600,000 | 0 | 405,000 | 0 |
| Application period | 2020-07-13 | 2,100,000 | 0 | 1,005,000 | 600,000 | 0 | 405,000 | 0 |
| Priced | 2020-07-21 | 2,100,000 | 696,000 | 1,005,000 | 600,000 | 0 | 405,000 | 0 |
※：( ) indicates the breakdown.
e.g. In the case of a PO(overseas), there are domestic and overseas allotments of the public offering, of which the overseas allotment is indicated.
PO : Public offering OA : Over allotment
